Sofía Pérez-Del-Pulgar
Research group
- Viral, genetic and immune-mediated liver diseases Accredited researcher (R3A-CIBER)
Featured publications
-
Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture
Authors:Reference: Nature Communications 2021. -
Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearance
Authors:Reference: Elife 2021. -
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
Authors:Reference: Journal Of Hepatology 2021. -
Hepatitis C virus intrinsic molecular determinants may contribute to the development of cholestatic hepatitis after liver transplantation
Authors:Reference: Journal Of General Virology 2019. -
Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antivirals.
Authors:Reference: Journal Of Viral Hepatitis 2018. -
Phylogenetic analysis of an epidemic outbreak of acute hepatitis C in HIV-infected patients by ultra-deep pyrosequencing
Authors:Reference: Journal Of Clinical Virology 2017. -
Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture
Authors:Reference: Nature Microbiology 2017. -
Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen
Authors:Reference: Gastroenterology 2016. -
Clinical relevance of the study of hepatitis B virus covalently closed circular DNA
Authors:Reference: Liver International 2016. -
Hepatitis C virus infection inhibits P-body granule formation in human livers
Authors:Reference: Journal Of Hepatology 2015.
Featured Projects
-
Study of cccDNA persistence during HBV infection in vivo, and in vitro using a bioreactor that mimics the liver microenvironment
Principal investigator: Sofia Perez del Pulgar GallartFunder: Instituto de Salud Carlos IIICode: PI16/00111Duration: 01/01/2017 - 31/12/2019 -
Virological and immunological factors associated with hepatitis C and hepatitis B virus infection recurrence after treatment discontinuation
Principal investigator: Xavier Forns BernhardtFunder: Gilead EspañaDuration: 07/03/2016 - 06/03/2018 -
TherVacB: A therapeutic vaccine to cure hepatitis B
Principal investigator: Xavier Forns BernhardtFunder: European CommissionCode: 848223Duration: 01/01/2020 - 31/12/2024 -
Interplay between HBV, HDV and host factors: impact on liver disease progression (InBDeL)
Principal investigator: Sofia Perez del Pulgar GallartFunder: ISCIII ; Instituto de Salud Carlos III (ISCIII)Code: PI19/00036Duration: 01/01/2020 - 31/12/2022 -
Viral and immune factors associated with antiviral treatment and hepatitis C recurrence after liver transplantation
Principal investigator: Sofia Perez del Pulgar GallartFunder: CIBER ENFERMEDADES HEPATICAS Y DIGESTIVAS (CIBEREHD) (Sede o evento); Instituto de Salud Carlos IIICode: PI13/00155Duration: 01/01/2014 - 30/03/2017